138 Preclinical activity and safety of MGD006, a CD123xCD3 Bispecific DART® molecule for the treatment of hematological malignancies

C.E. Engeland, R. Veinalde, C. Grossardt, S. Bossow, I. Shevchenko, V. Umansky, D.M. Nettelbeck, D. Jager, C. von Kalle, G. Ungerechts. National Center for Tumor Diseases (NCT), Translational Oncology, Heidelberg, Germany; German Cancer Research Center (DKFZ), Clincal Cooperation Unit Dermato-Oncology, Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Medical Oncology, Heidelberg, Germany; National Center for Tumor Diseases (NCT), Translational Oncology and Medical Oncology, Heidelberg, Germany